» Articles » PMID: 1972994

Animal Models of Drug Withdrawal Symptoms

Overview
Specialty Pharmacology
Date 1990 Jan 1
PMID 1972994
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

There have been few attempts to model subjective symptoms of drug withdrawal using animals as subjects. Two approaches for developing such models are reviewed. First, using drug discrimination methodology, it may be possible to train animals to detect the effects of withdrawal. This method has two difficulties: 1) the only discriminations trained to date involve precipitated withdrawal, and 2) the stimulus controlling behavior is difficult to specify. Second, withdrawal from many drugs of abuse produces the symptom of anxiety, and it seems likely that animal models of anxiety could be useful for studying drug withdrawal. This hypothesis has been explored most fully using subjects trained to detect the discriminative stimulus properties of the putative anxiogenic drug pentylenetetrazole (PTZ). Withdrawal from benzodiazepines or ethanol substitutes fully for PTZ, and withdrawal from cocaine, morphine, and nicotine substitutes partially for PTZ. Emerging data suggest that other animal models of anxiety may also be useful for detecting drug withdrawal. The final portion of this review examines a behavioral test that is very sensitive for detecting physical signs of withdrawal in animals. In subjects maintained on an operant baseline using food as a reinforcer, withdrawal from a drug of dependence frequently is associated with disruption of that operant behavior. For example, tetrahydrocannabinol and cocaine, drugs that are not traditionally seen as having significant withdrawal signs, produce disruption of operant responding when high-dose administration is terminated, and their readministration reverses this behavioral disruption. Based on the observation that withdrawal is associated with anxiogenic stimuli, we suggest a method to determine if disruption of operant behavior may be related to these stimuli.

Citing Articles

An economon model of drug addiction.

Negus S Psychopharmacology (Berl). 2024; 241(3):417-425.

PMID: 38277005 PMC: 10884072. DOI: 10.1007/s00213-024-06535-7.


Differential disruption of response alternation by precipitated Δ-THC withdrawal and subsequent Δ-THC abstinence in mice.

Eckard M, Kinsey S Pharmacol Biochem Behav. 2024; 236:173718.

PMID: 38272272 PMC: 10955601. DOI: 10.1016/j.pbb.2024.173718.


Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice.

Collins H, Pinacho R, Ozdemir D, Bannerman D, Sharp T J Psychopharmacol. 2022; 36(7):794-805.

PMID: 35607713 PMC: 9247435. DOI: 10.1177/02698811221093032.


Confronting the challenge of failed translation in medications development for substance use disorders.

Negus S, Banks M Pharmacol Biochem Behav. 2021; 210:173264.

PMID: 34461148 PMC: 8418188. DOI: 10.1016/j.pbb.2021.173264.


Gabapentin attenuates somatic signs of precipitated THC withdrawal in mice.

Eckard M, Kinsey S Neuropharmacology. 2021; 190:108554.

PMID: 33845073 PMC: 8204917. DOI: 10.1016/j.neuropharm.2021.108554.


References
1.
Spealman R . Disruption of schedule-controlled behavior by Ro 15-1788 one day after acute treatment with benzodiazepines. Psychopharmacology (Berl). 1986; 88(3):398-400. DOI: 10.1007/BF00180845. View

2.
Woolverton W, Kleven M . Evidence for cocaine dependence in monkeys following a prolonged period of exposure. Psychopharmacology (Berl). 1988; 94(2):288-91. DOI: 10.1007/BF00176861. View

3.
Mathis D, Harris C, Idemudia S, Lal H . Withdrawal from diazepam substitutes for the discriminative stimulus properties of pentylenetetrazol. J Pharmacol Exp Ther. 1988; 244(3):892-7. View

4.
Shearman G, Lal H . Discriminative stimulus properties of cocaine related to an anxiogenic action. Prog Neuropsychopharmacol. 1981; 5(1):57-63. DOI: 10.1016/0364-7722(81)90005-9. View

5.
Stephens D, SCHNEIDER H . Tolerance to the benzodiazepine diazepam in an animal model of anxiolytic activity. Psychopharmacology (Berl). 1985; 87(3):322-7. DOI: 10.1007/BF00432715. View